SEC Form D private-offering filing

Lycia Therapeutics, Inc.

Name: Lycia Therapeutics, Inc. - new SEC Form D private-offering filing, South San Francisco, CA
Published: 2026-06-25

A new SEC Form D private-offering notice from South San Francisco, CA, a $75,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Lycia Therapeutics, Inc. site↗ Verified via SEC Form D

Biotech developing LYTAC lysosome targeting protein degrader therapeutics, based on a platform from Stanford's Carolyn Bertozzi, focused on autoimmune and inflammatory disease.

Filed 2026-06-25Filed to raise $75,000,000First money in 2026-06-10Raised so far $75,000,000HQ (as filed) South San Francisco, CASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified lyciatx.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.